About Early-onset autoinflammatory syndrome due to A20 haploinsufficiency
Early-onset autoinflammatory syndrome due to A20 haploinsufficiency is a rare disease catalogued by Orphanet (ORPHA:674762). It is associated with the TNFAIP3 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Early-onset autoinflammatory syndrome due to A20 haploinsufficiency trials.
Search ClinicalTrials.gov for "Early-onset autoinflammatory syndrome due to A20 haploinsufficiency" or filter by Orphanet code ORPHA:674762 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Early-onset autoinflammatory syndrome due to A20 haploinsufficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Early-onset autoinflammatory syndrome due to A20 haploinsufficiency. Updated daily.